DEVELOPING A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR QUANTITATIVE CHARACTERIZATION OF EXOGENOUSLY ADMINISTERED T CELLS.

被引：0
|
作者：
Khot, A. [1 ]
Shah, D. K. [1 ]
机构：
[1] SUNY Buffalo, Buffalo, NY USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2019年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PBPK-007
引用
收藏
页码：S6 / S6
页数：1
相关论文
共 50 条
  • [31] A guide to developing population files for physiologically-based pharmacokinetic modeling in the Simcyp Simulator
    Curry, Liam
    Alrubia, Sarah
    Bois, Frederic Y.
    Clayton, Ruth
    El-Khateeb, Eman
    Johnson, Trevor N.
    Faisal, Muhammad
    Neuhoff, Sibylle
    Wragg, Kris
    Rostami-Hodjegan, Amin
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (09): : 1429 - 1447
  • [32] A physiologically-based pharmacokinetic model for predicting doxorubicin disposition in multiple tissue levels and quantitative toxicity assessment
    Chao, Fang-Ching
    Manaia, Eloisa Berbel
    Ponchel, Gilles
    Hsieh, Chien-Ming
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
  • [33] Measurement and Quantitative Characterization of Whole-Body Pharmacokinetics of Exogenously Administered T Cells in Mice
    Khot, Antari
    Matsueda, Satoko
    Thomas, Veena A.
    Koya, Richard C.
    Shah, Dhaval K.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2019, 368 (03): : 503 - 513
  • [34] Development of a Pediatric Physiologically-Based Pharmacokinetic Model of Clindamycin Using Opportunistic Pharmacokinetic Data
    Hornik, Christoph P.
    Wu, Huali
    Edginton, Andrea N.
    Watt, Kevin
    Cohen-Wolkowiez, Michael
    Gonzalez, Daniel
    CLINICAL PHARMACOKINETICS, 2017, 56 (11) : 1343 - 1353
  • [35] A Δ9-Tetrahydrocannabinol Physiologically-Based Pharmacokinetic Model Development in Humans
    Methaneethorn, Janthima
    Poomsaidorn, Chomkanang
    Naosang, Kanyamas
    Kaewworasut, Parichart
    Lohitnavy, Manupat
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45 (04) : 495 - 511
  • [36] Evaluating a physiologically-based pharmacokinetic model for use in risk assessment.
    Clark, LH
    Barton, HA
    Setzer, RW
    TOXICOLOGICAL SCIENCES, 2003, 72 : 182 - 182
  • [37] Physiologically-based pharmacokinetic model for pregnancy as a tool for investigation of developmental mechanisms
    Young, JF
    COMPUTERS IN BIOLOGY AND MEDICINE, 1998, 28 (04) : 359 - 364
  • [38] Physiologically-based pharmacokinetic model for pulmonary disposition of protein therapeutics in humans
    Jagdale, Prabhas
    Sepp, Armin
    Shah, Dhaval K.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2022, 49 (06) : 607 - 624
  • [39] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL TO SUPPORT OPHTHALMIC SUSPENSIONS DEVELOPMENT.
    Le Merdy, M.
    Fan, J.
    Babiskin, A. H.
    Zhao, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S7 - S7
  • [40] Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles
    Carlander, Ulrika
    Li, Dingsheng
    Jolliet, Olivier
    Emond, Claude
    Johanson, Gunnar
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2016, 11 : 625 - 640
12345